Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients

Nonalcoholic fatty liver disease (NAFLD) is a rising indication for liver transplantation (LT). Identification of NAFLD recurrence and those at risk for more progressive disease after LT remains elusive as the diagnosis requires biopsy, which is invasive and impractical for serial monitoring. We the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mowry, Christopher J., Alonso, Cristina, Iruarrizaga-Lejarreta, Marta, Ortiz, Pablo, Levitsky, Josh, Rinella, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580200/
https://www.ncbi.nlm.nih.gov/pubmed/34778544
http://dx.doi.org/10.1097/TXD.0000000000001227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580200/
https://www.ncbi.nlm.nih.gov/pubmed/34778544
http://dx.doi.org/10.1097/TXD.0000000000001227

Ejemplares similares